These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1294683)

  • 1. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events.
    Badawy YA; Bayoumi DM
    J Egypt Public Health Assoc; 1992; 67(5-6):579-91. PubMed ID: 1294683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of ovarian cancer in Greece: a case-control study.
    Tzonou A; Day NE; Trichopoulos D; Walker A; Saliaraki M; Papapostolou M; Polychronopoulou A
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1045-52. PubMed ID: 6540687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual factors and the risk of epithelial ovarian cancer.
    Parazzini F; La Vecchia C; Negri E; Gentile A
    J Clin Epidemiol; 1989; 42(5):443-8. PubMed ID: 2732772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics that predict risk of breast cancer before and after the menopause.
    Paffenbarger RS; Kampert JB; Chang HG
    Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ovarian cancer: a case-control study.
    Booth M; Beral V; Smith P
    Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of the epidemiology of ovarian cancer.
    La Vecchia C; Franceschi S; Liberati A; Gallus G; Tognoni G
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):175-82. PubMed ID: 6368240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of breast cancer in relation to reproductive factors in Denmark.
    Ewertz M; Duffy SW
    Br J Cancer; 1988 Jul; 58(1):99-104. PubMed ID: 3166899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.